<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Any other business

It was a hot weekend for takeover deals – and cycling

12 May 2018

9:00 AM

12 May 2018

9:00 AM

The bank holiday turned out to be a hot one, not least in the takeover arena. First, Shire Pharmaceutical accepted a £46 billion offer from Takeda of Japan — though the stock market did not seem wholly convinced that the deal will proceed. If it does, should we care?

Shire is a FTSE100 company that began in the UK and ended up stateless.

Already a subscriber? Log in

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER

You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.


Comments

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

Already a subscriber? Log in

Close